Reassortant rotaviruses as potential live rotavirus vaccine candidates.
A series of reassortants was isolated from coinfection of cell cultures with a wild-type animal rotavirus and a "noncultivatable" human rotavirus. Wild-type bovine rotavirus (UK strain) was reassorted with human rotavirus strains D, DS-1, and P; wild-type rhesus rotavirus was reassorted with human rotavirus strains D and DS-1. The D, DS-1, and P strains represent human rotavirus serotypes 1, 2, and 3, respectively. Monospecific antiserum (to bovine rotavirus, NCDV strain) or a set of monoclonal antibodies to the major outer capsid neutralization glycoprotein, VP7 (of the rhesus rotavirus), was used to select for reassortants with human rotavirus neutralization specificity. This selection technique yielded many reassortants which received only the gene segment coding for the major neutralization protein from the human rotavirus parent, whereas the remaining genes were derived from the animal rotavirus parent. Single human rotavirus gene substitution reassortants of this sort represent potential live vaccine strains.
Midthun
K
K
Greenberg
H B
HB
Hoshino
Y
Y
Kapikian
A Z
AZ
Wyatt
R G
RG
Chanock
R M
RM
D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology; D002522:Chlorocebus aethiops; D003433:Crosses, Genetic; D006801:Humans; D012401:Rotavirus / Q000235:genetics* / Q000276:immunology; D014765:Viral Vaccines
D000911:Antibodies, Monoclonal; D014765:Viral Vaccines